Pavel Aprelev

Dr. Aprelev is a start-up member and a Director of Corporate Development for Verismo Therapeutics. Prior to joining Verismo, Dr. Aprelev spent two years as a postdoc in the translational research lab at Perelman School of Medicine at the University of Pennsylvania. There, he led a project on targeted drug delivery using mural and human red blood cell hitchhiking. He organized and managed the workflow of cross-functional teams of scientists, engineers, and medical doctors to achieve unprecedented drug delivery efficacy to the pulmonary endothelium, which resulted in two federal grants, an NIH fellowship, a provisional patent, and several peer-reviewed publications. During this time, Dr. Aprelev also completed a fellowship at the University of Pennsylvania technology transfer office, where he analyzed the patentability and the marketability of new inventions. Dr. Aprelev obtained his PhD in Materials Science and Engineering from Clemson University in 2018. During his PhD, he developed a new technology to probe the physical properties of blood at nano- and micro- scales and led teams of PhD and undergraduate students to understand the molecular origins of interfacial interaction and nano-rheology of clotting insect blood, as results of which, he received a 2-year NASA Graduate Fellowship, authored nine publications, presented seven oral and six poster presentations, and helped jump-start numerous successful scientific careers. He received his BS with honors in Physics with minors in Economics and Mathematics from Union College in 2013.